Evidence Based Review on Emerging Treatment for Menopausal Symptoms
Tabassum K*
Department of Ilmul Qabalat wa Amraze Niswan, Govt. Unani Medical College and Hospital, Bangalore, KA, India
*Corresponding Author: Tabassum K, Department of Ilmul Qabalat wa Amraze Niswan, Govt. Unani Medical College and Hospital, Bangalore, KA, India.
Received: January 11, 2024; Published: July 16, 2024
Abstract
“Menopause - A pause while Women reconsider Men and it change the life” Menopause is a natural biological process occur after 40 years in every women's life. But the physical symptoms, such as hot flashes, and emotional symptoms of menopause may disrupt your sleep, lower your energy or affect emotional health. The mean age of menopause is 49.4 years and 130 million Indian women are expected to live beyond menopause into old age by 2015. In India 19% of women age 40-41 have already reached menopause, and the incidence of menopause is increases rapidly after 41. By the age of 48-49 years two third of women are in menopause. So, the number of women in menopause is increasing with increase in life expectancy and so is the increase in reported problems. Therefore, quality of this population becomes a major issue and understanding of menopause is very important issue. Long term use of HRT has been associated with increased risks for venous thromboembolism, coronary heart diseases, stroke and breast cancer. In classical unani text, though menopausal transition is not mentioned as such, but its clinical features can be correlated with complications occurring due to Ehtebase haiz (Ammenorrhoea). There are many effective treatments available, from lifestyle adjustments to hormone therapy. In unani system of medicinr many herbal medicines are documented to alleviate these symptoms. Herbal medicines include Asgandh, Soya, Alsi, Todari, Aslasoos etc. This review paper focuses on herbal medicines which are useful in menopausal syndrome.
Keywords: Menopause; Biological Changes; Unani Herbal Medicine; Management
References
- Practice committee of the American Society for reproductive”. The Journal of Menopausal Transition, Fertility and Sterility 10 (2016): 86.
- Dutta DC. “Text Book of Gynecology, New central book agency, Calcutta, India (2000): 48-51.
- Jeffcoat’s principles of Gynecology, Pratap Kumar and Narender Malhotra, Jaypee Brother Medical publishers, 7th edition (1986): 862-873.
- Kumar P and Malhotra N. “Jeffcoat’s Principles of Gynaecology”. Jaypee publishers, New Delhi (2008): 862.
- Seven teachers, text book of gynaecology (2010): 41-50.
- Text Book of Gynecology, Berek and Novak’s Lippin Cott Williams and Wilkins, 14th edition (2007): 1323-1330.
- Mangione CM., et al. “NIH state of the science conference statement on management of menopause related symptoms”. NIH Consensus State Science Statements1 (2005): 1-38.
- Nelson HD., et al. “Management of menopause related symptoms”. AHRQ evidence report/Technology/Assessment 120 (2005): 1-916.
- Buist DS., et al. “Use of alternative therapies for menopausal symptoms; results of a population based survey”. Obstetrics and Gynecology1 (2002): 18-25.
- Khan Al Umoor-Al Tibiya. “Aizaj publication, New Delhi (2000): 46-56.
- Jurjani AH. “Tarjumae Zakheera Khwarzam Shahi (Trans: Khan HH). New Delhi: Idara Kitabus Shifa (2010): 599-600.
- Razi ABZ. “Kitabul Hawi. Vol. 9. CCRUM: New Delhi (2001): 151-158.
- Ibn Sina., et al. “Idrae Kitabushifa” New Delhi (2010): 1095-1097.
- Wassertheil-Smoller S., et al. “Effect of estrogen plus progestin on stoke in post-menopausal women, The Women’s Health Initiative-Randomized controlled trial”. JAMA 20 (2003): 2673-2684.
- Anderson GL., et al. “Effects of conjugated equine estrogen in post-menopausal women with hystectomy, The women’s Health Initiative-Randomized controlled trial”. JAMA 14 (2004): 1701-1712.
- Writing Group for the Women's Health Initiative Investigators. “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial”. JAMA 288 (2002): 321-333.
- Birkhauser MH., et al. “Updated practical recommendations for hormone replacement therapy in the peri- and post menopause”. Climacteric 11 (2008): 108-123.
- Newton KM., et al. “Use of alternative therapies for menopausal symptoms; results of a population-based survey”. Obstetrics and Gynecology 1 (2002): 18-25.
- Dawn CS. “Text book of Gynecology, Dawn books, Calcutta, 10th edition (1990): 81-82.
- Rossow JE., et al. “Risks and benefits of estrogen plus progestin in healthy postmenopausal women; principal results from the women’s Health Initiative-Randomized controlled trial”. JAMA3 (2002): 321-333.
- Mohd Hakeem. “Bustanul Mufradat, Lucknow 20 (2013): 100
- Syed Safiuddin, Advia Mufradat 16.31 (2012): 279.
- Kabiruddin and Bayaz Kabir. “Maktaba Naimia”. U.P (2011): 143
- National Center for Complementary and Alternative Medicine (2010).
- Lethaby AE., et al. “Phytoestrogens for vasomotor menopausal symptoms”. Cochrane Database of Systematic Reviews 4 (2007): 24-27.
- Setchell Setchell KDR and Adlercreutz H. “Mammalian ligans and phytoestrogens: recent studies on their formation, metabolism, and biological role in health and disease”. In: Rowland I., Editor, Role of the gut flora in toxicity and cancer, Academic Press, London (2014): 315-345.
- Kuiper Kuiper G., et al. “Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta”. Endocrinology10 (2000): 4252-4263.
- A Cassidy., et al. “Biologic effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women”. The American Journal of Clinical Nutrition 60 (2018): 333-340.
- Ghani HN Khazainul advia YNM. “Delhi:Idara kitabul shifa New Delhi” (2011): 362.
- Salpeter SR., et al. “Brief report. Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis”. Journal of General Internal Medicine 21 (2006): 363-366.
- Butt DA., et al. “Gabapentin for the treatment of menopausal depression and anxiety:a randomized controlled trial”. Menopause 15 (2008): 310-318.
- Van der Laak JA., et al. “The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerized cytometry”. Journal of Clinical Pathology 55 (2002): 446-451.
- Notelovitz M. “Urogenital aging: solutions in clinical practice”. International Journal of Gynecology and Obstetrics 1 (2007): S35-39.
- Kleijnen and Kleijnen J. “Evening primrose oil: currently used in many conditions with little justification”. British Medical Journal 1 (2017): 824-825.
- Lucero MA and McCloskey WW. “Evening primrose Alternatives to estrogen for the treatment of hot flashes”. Annals of Pharmacotherapy 31 (2011): 915-917.
- Geller SE and Studee L. “Contemporary alternatives to plant estrogens for menopause”. Maturitas 1 (2010): 3-13.
- Center for Nutrition Policy and Promotion (CNPP), United States Department of Agriculture (2015): 34-46.
- Dietary Guidelines for Americans (2018).
- K Elkind-Hirsch. “Effect of dietary phyto-estrogens on hot flushes: Glycyrrhiza glabra Linn for traditional estrogen replacement therapy?” Menopause3 (2015): 154-156.
- Knight Knight DC., et al. “Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation”. Climacteric 4 (2018): 13-18.
- Cashman K. “Diet, nutrition and bone health”. Journal of Nutrition 137 (2007): 2507-2512.
- Campbell W and Leidy H. “Dietary protein and resistance training effects on muscle and body composition in older persons”. Journal of the American College of Sports Nutrition (2017): 26-30.
- Allen L. “How common is vitamin deficiency?” American Journal of Clinical Nutrition (2019): 34-37.
Citation
Copyright